Universal-Beteiligungs- und Servicegesellschaft
CYTK icon

Universal-Beteiligungs- und Servicegesellschaft’s Cytokinetics CYTK Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.95M Buy
116,828
+61,438
+111% +$4.41M 0.02% 656
2026
Q1 		$3.65M Buy
55,390
+1,112
+2% +$70.7K 0.01% 1009
2025
Q4 		$3.45M Buy
54,278
+23,571
+77% +$1.47M 0.01% 1060
2025
Q3 		$1.69M Buy
30,707
+5,536
+22% +$228K ﹤0.01% 1363
2025
Q2 		$832K Buy
25,171
+236
+0.9% +$8.21K ﹤0.01% 1551
2025
Q1 		$1M Buy
+24,935
New +$1.15M ﹤0.01% 1461

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CYTK Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Cytokinetics (CYTK) stake by 111% in Q2 2026, buying an estimated $4.41M and bringing the position to 116,828 shares worth $9.95M. The position accounts for 0.02% of the portfolio, ranked #656.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CYTK in Q1 2025 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 116,828 shares of Cytokinetics worth $9.95M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 61,438 Cytokinetics shares in Q2 2026, an estimated $4.41M.
  • Cytokinetics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #656 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Cytokinetics in Q1 2025 and has held it in 6 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.